10 Results for "

BRD4-IN-12

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "BRD4-IN-12" in MCE Product Catalog:

Cat. No.: HY-181505
CAS No.: 3112325-99-9
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC50 of 7.9 nM. BRD4-IN-12 downregulates the expression of c-MYC, BCL-2, CDK4 and upregulates p21. BRD4-IN-12 inhibits tumor cell proliferation and promotes apoptosis. BRD4-IN-12 exhibits excellent antitumor effects in the HCT-116 colorectal cancer xenograft model. BRD4-IN-12 can be used for the study of colorectal cancer (CRC) .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-107425
CAS No.: 1797406-69-9
Purity:  99.86%
Research Areas:  

Cancer

MZ 1 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. MZ 1 potently and rapidly induces reversible, long-lasting, and selective removal of BRD4 over BRD2 and BRD3. Kds of 382/120, 119/115, and 307/228 nM for BRD4 BD1/2, BRD3 BD1/2, and BRD2 BD1/2, respectively .
loading...
    loading...
Cat. No.: HY-178041
CAS No.: 3106588-54-6
BRD4-BD1/2-IN-3 (Compound B6) is a selective BRD4 BD2 inhibitor with an IC50 of 0.41  nM for BRD4 BD2 over BRD4 BD1. BRD4-BD1/2-IN-3 significantly inhibits the LPS (HY-D1056)-induced expression of IL-6. BRD4-BD1/2-IN-3 shows anti-inflammatory activities by modulating the TNF and NF-κB signaling pathway. BRD4-BD1/2-IN-3 can be used for inflammatory diseases research .
loading...
    loading...
Cat. No.: HY-176476
Research Areas:  

Cancer

BRD4/FKBP12 ligand 2 is a heterobifunctional BRD4 and FKBP12 (Kd of 1.0 nM) ligand. BRD4/FKBP12 ligand 2 has positive cooperativity in BRD4 binding when pre-bound to FKBP12, and FKBP12-dependent cytotoxicity in cancer cells via the CellTrap effect. BRD4/FKBP12 ligand 2 can be used for the research of hematopoietic malignancy, multiple myeloma, prostate carcinoma, acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-142675
CAS No.: 2743464-27-7
Research Areas:  

Cancer

BRD4-BD1/2-IN-2 is a potent BRD4 BD2 inhibitor with IC50s of <0.5 nM and <300 nM for BRD4 BD2 and BRD4 BD1, respectively (WO2021233371A1, compound 2) .
loading...
    loading...
Cat. No.: HY-176477
Research Areas:  

Cancer

BRD4/FKBP12 ligand 1 is a heterobifunctional BRD4 and FKBP12 (Kd of 0.4 nM) ligand. BRD4/FKBP12 ligand 1 has positive cooperativity in BRD4 binding when pre-bound to FKBP12, and FKBP12-dependent cytotoxicity in cancer cells via the CellTrap effect. BRD4/FKBP12 ligand 1 can be used for the research of acute myeloid leukemia, multiple myeloma, prostate carcinoma .
loading...
    loading...
Cat. No.: HY-132128
CAS No.: 328956-24-7
Research Areas:  

Cancer

BRD4 Inhibitor-12 (Compound 9) is a BRD4 ligand, and can be used for research of cancer, infammation .
loading...
    loading...
Cat. No.: HY-138553A
Purity:  98.86%
Research Areas:  

Cancer

(S,R,S)-AHPC-isobutyl acetate-methanesulfonothioate-Me-C10-NH2 TFA is a part of PROTAC BRD4 Degrader-12 (HY-138635) .
loading...
    loading...
Cat. No.: HY-142674
CAS No.: 1781219-19-9
Research Areas:  

Cancer

BRD4-BD1/2-IN-1 is a potent BRD4 inhibitor with IC50s of <100 nM for BRD4 BD-1 and BRD4 BD-2, respectively (US20150148375A1, compound 5) .
loading...
    loading...
Cat. No.: HY-107425R
CAS No.: 1797406-69-9
MZ 1 (Standard) is the analytical standard of MZ 1 (HY-107425). This product is intended for research and analytical applications. MZ 1 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. MZ 1 potently and rapidly induces reversible, long-lasting, and selective removal of BRD4 over BRD2 and BRD3. Kds of 382/120, 119/115, and 307/228 nM for BRD4 BD1/2, BRD3 BD1/2, and BRD2 BD1/2, respectively .
loading...
    loading...